If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.50
Bid: 15.00
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 1.00 (6.667%)
Open: 15.50
High: 15.50
Low: 15.50
Prev. Close: 15.50
THRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Annual General Meeting

21 Sep 2023 11:12

RNS Number : 2343N
Thruvision Group PLC
21 September 2023
 

21 September 2023

Thruvision Group plc

 

Result of Annual General Meeting

 

Thruvision Group plc (AIM: THRU), the leading provider of walk-through security technology, announces that following the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed by the requisite majority. The number of proxies received in respect of each resolution were as follows:

 

Resolution

Total votes for

%

Total votes against

%

Total votes cast

Votes withheld

1.

Receipt of directors and auditors report

115,672,112

100.00

0

0.00

115,672,112

2,922

2.

Approval of remuneration report

115,595,721

99.94

69,972

0.06

115,665,693

9,341

3.

Re-election of Tom Black

115,667,442

100.00

4,670

0.00

115,672,112

2,922

4.

Re-election of Colin Evans

115,667,442

100.00

4,670

0.00

115,672,112

2,922

5.

Re-election of Richard Amos

115,662,442

100.00

4,670

0.00

115,667,112

7,922

6.

Re-election of Katrina Nurse

115,662,442

99.99

9,670

0.01

115,672,112

2,922

7.

Re-election of Victoria Balchin

115,662,442

99.99

9,670

0.01

115,672,112

2,922

8.

Re-appointment of Auditors

115,657,442

99.99

14,670

0.01

115,672,112

2,922

9.

Authority for Directors to set Auditors remuneration

115,667,442

100.00

4,670

0.00

115,672,112

2,922

10. 

Authority for Directors to allot equity securities

115,661,873

99.99

10,239

0.01

115,672,112

2,922

11. 

Authority for Directors to allot equity securities for cash on a non-premptive basis

115,639,873

99.97

32,239

0.03

115,672,112

2,922

12. 

Authority for Directors to allot equity securities for cash in respect of an acquisition or other capital project.

115,634,873

99.97

32,239

0.03

115,667,112

7,922

13. 

Authority for the Company to make market purchases of its own Ordinary Shares

115,645,112

99.98

22,000

0.02

115,667,112

7,922

14. 

Authority for the Directors to extend the life of the Thruvison Sharesave Scheme

115,666,023

100.00

4,670

0.00

115,670,693

4,341

 

 

Notes

1. Any proxy appointments which gave discretion to the Chairman have been included in the 'Total votes for' total.

2. A 'Vote Withheld' is not a valid vote in law and was not counted in the calculation of the proportion of the votes 'for' or 'Against' a resolution. 

3. All percentages have been rounded to two decimal places.

 

 

For further information please contact:

 

Thruvision Group plc

Colin Evans, Chief Executive

Victoria Balchin, Chief Financial Officer

+44 (0)1235 425400

Investec Investment Banking (NOMAD & Broker)

James Rudd / Patrick Robb / Sebastian Lawrence

+44 (0)20 7597 5970

 

Meare Consulting

Adrian Duffield

+44 (0) 7990 858548

 

About Thruvision (www.thruvision.com)

Thruvision is the leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 20 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group has offices and manufacturing capability in the UK and US.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKDBKKBKDBCB
Date   Source Headline
21st Feb 20222:07 pmRNSExercise of Sharesave Share Options
25th Jan 20224:06 pmRNSSharesave option grant to Executive Director
24th Dec 20217:00 amRNSDirector Share Dealing
22nd Dec 202112:42 pmRNSHolding(s) in Company
2nd Dec 20216:00 pmRNSDirector Share Dealing
2nd Dec 20212:00 pmRNSInvestor Presentation
1st Dec 202111:36 amRNSDirector Share Dealing
30th Nov 20215:39 pmRNSAward of Share Options to Executive Directors
30th Nov 20211:50 pmRNSDirector Share Dealing
22nd Nov 20217:00 amRNSInterim Results
11th Nov 20217:00 amRNSNotice of Interim Results
27th Oct 20218:52 amRNSBlocklisting application
7th Oct 20217:00 amRNSTrading Update
4th Oct 20219:10 amRNSBlocklisting update
28th Sep 202110:31 amRNSResult of Annual General Meeting
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSDirector Share Dealing
27th Jul 20211:00 pmRNSDirector/PDMR Shareholding
16th Jul 20213:27 pmRNSReplacement: Holding(s) in Company
15th Jul 20214:43 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSResults for the Year ended 31 March 2021
9th Jul 20212:34 pmRNSReplacement: Investor Presentation
9th Jul 202111:00 amRNSInvestor Presentation
5th Jul 202112:00 pmRNSNotice of Results
27th May 20211:24 pmRNSDirector Share Dealing
1st Apr 20217:00 amRNSPre-Close Statement
31st Mar 20213:00 pmRNSBlocklisting update
11th Mar 20215:53 pmRNSHolding(s) in Company
10th Mar 20213:33 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSAppointment of Non-Executive Director
1st Dec 20207:00 amRNSThruvision Investor Presentation
23rd Nov 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSNotice of Interim Results
9th Oct 202010:18 amRNSHolding(s) in Company
7th Oct 20207:00 amRNSPre-close Trading Update
22nd Sep 202010:31 amRNSResult of Annual General Meeting
18th Sep 20207:00 amRNSContract award announcement
26th Jun 202010:32 amRNSHolding(s) in Company
23rd Jun 20205:21 pmRNSHolding(s) in Company
22nd Jun 20204:24 pmRNSHolding(s) in Company
17th Jun 202011:05 amRNSSecond Price Monitoring Extn
17th Jun 202011:01 amRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSAward of Share Options to Executive Directors
8th Jun 20207:00 amRNSResults for the Year ended 31 March 2020
3rd Jun 20207:22 amRNSNotice of Annual Results
3rd Jun 20207:00 amRNSNotice of Annual Results
2nd Apr 20207:40 amRNSTrading Statement
25th Nov 20197:00 amRNSInterim Results
19th Nov 20197:00 amRNSNotice of Interim Results
13th Nov 20193:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.